Results from the FELIX trial support the approval of obecabtagene autoleucel in B-cell ALL.
Approval Alert | Obecabtagene Autoleucel in B-Cell Acute Lymphoblastic Leukemia
Advertisement
Advertisement
Trending on CancerNetwork
1
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
4
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
5
